nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—Zoledronate—osteoporosis	0.131	0.258	CrCtD
Clodronate—Etidronic acid—osteoporosis	0.131	0.258	CrCtD
Clodronate—Pamidronate—osteoporosis	0.123	0.242	CrCtD
Clodronate—Alendronate—osteoporosis	0.123	0.242	CrCtD
Clodronate—PTGS2—Risedronate—osteoporosis	0.0611	1	CbGbCtD
Clodronate—Zoledronate—Ibandronate—osteoporosis	0.0242	0.0707	CrCrCtD
Clodronate—Etidronic acid—Ibandronate—osteoporosis	0.0242	0.0707	CrCrCtD
Clodronate—Pamidronate—Ibandronate—osteoporosis	0.0214	0.0625	CrCrCtD
Clodronate—Alendronate—Ibandronate—osteoporosis	0.0214	0.0625	CrCrCtD
Clodronate—Zoledronate—Risedronate—osteoporosis	0.017	0.0498	CrCrCtD
Clodronate—Etidronic acid—Zoledronate—osteoporosis	0.017	0.0498	CrCrCtD
Clodronate—Zoledronate—Etidronic acid—osteoporosis	0.017	0.0498	CrCrCtD
Clodronate—Etidronic acid—Risedronate—osteoporosis	0.017	0.0498	CrCrCtD
Clodronate—Etidronic acid—Alendronate—osteoporosis	0.016	0.0468	CrCrCtD
Clodronate—Zoledronate—Alendronate—osteoporosis	0.016	0.0468	CrCrCtD
Clodronate—Etidronic acid—Pamidronate—osteoporosis	0.016	0.0468	CrCrCtD
Clodronate—Zoledronate—Pamidronate—osteoporosis	0.016	0.0468	CrCrCtD
Clodronate—Alendronate—Zoledronate—osteoporosis	0.015	0.044	CrCrCtD
Clodronate—Pamidronate—Zoledronate—osteoporosis	0.015	0.044	CrCrCtD
Clodronate—Alendronate—Etidronic acid—osteoporosis	0.015	0.044	CrCrCtD
Clodronate—Alendronate—Risedronate—osteoporosis	0.015	0.044	CrCrCtD
Clodronate—Pamidronate—Etidronic acid—osteoporosis	0.015	0.044	CrCrCtD
Clodronate—Pamidronate—Risedronate—osteoporosis	0.015	0.044	CrCrCtD
Clodronate—Alendronate—Pamidronate—osteoporosis	0.0141	0.0414	CrCrCtD
Clodronate—Pamidronate—Alendronate—osteoporosis	0.0141	0.0414	CrCrCtD
Clodronate—Pamidronate—FDPS—osteoporosis	0.00118	0.457	CrCbGaD
Clodronate—Alendronate—FDPS—osteoporosis	0.000619	0.24	CrCbGaD
Clodronate—Zoledronate—FDPS—osteoporosis	0.000612	0.237	CrCbGaD
Clodronate—PTGS2—periosteum—osteoporosis	0.000452	0.242	CbGeAlD
Clodronate—SLC25A6—uterus—osteoporosis	0.000378	0.202	CbGeAlD
Clodronate—SLC25A5—uterus—osteoporosis	0.000328	0.175	CbGeAlD
Clodronate—SLC25A6—bone marrow—osteoporosis	0.00032	0.171	CbGeAlD
Clodronate—SLC25A5—bone marrow—osteoporosis	0.000279	0.149	CbGeAlD
Clodronate—Zoledronate—CA2—osteoporosis	0.000169	0.0655	CrCbGaD
Clodronate—Anorexia—Calcium Acetate—osteoporosis	0.000156	0.00278	CcSEcCtD
Clodronate—Bronchospasm—Ibandronate—osteoporosis	0.000155	0.00274	CcSEcCtD
Clodronate—Renal failure acute—Pamidronate—osteoporosis	0.000154	0.00274	CcSEcCtD
Clodronate—Hypocalcaemia—Estradiol—osteoporosis	0.000151	0.00268	CcSEcCtD
Clodronate—Cardiac failure—Pamidronate—osteoporosis	0.000146	0.00259	CcSEcCtD
Clodronate—Hepatic function abnormal—Conjugated Estrogens—osteoporosis	0.000143	0.00255	CcSEcCtD
Clodronate—Decreased appetite—Calcium Acetate—osteoporosis	0.000143	0.00253	CcSEcCtD
Clodronate—Pneumonia—Raloxifene—osteoporosis	0.000142	0.00253	CcSEcCtD
Clodronate—Pneumonia—Ibandronate—osteoporosis	0.000141	0.0025	CcSEcCtD
Clodronate—Renal failure acute—Zoledronate—osteoporosis	0.000141	0.0025	CcSEcCtD
Clodronate—Anorexia—Ergocalciferol—osteoporosis	0.000138	0.00245	CcSEcCtD
Clodronate—Renal failure—Ibandronate—osteoporosis	0.000138	0.00245	CcSEcCtD
Clodronate—Abdominal pain upper—Risedronate—osteoporosis	0.000137	0.00243	CcSEcCtD
Clodronate—Renal impairment—Zoledronate—osteoporosis	0.000137	0.00243	CcSEcCtD
Clodronate—Renal failure acute—Conjugated Estrogens—osteoporosis	0.000136	0.00241	CcSEcCtD
Clodronate—Blood creatinine increased—Pamidronate—osteoporosis	0.000133	0.00237	CcSEcCtD
Clodronate—Renal impairment—Conjugated Estrogens—osteoporosis	0.000132	0.00234	CcSEcCtD
Clodronate—Pharyngitis—Estropipate—osteoporosis	0.00013	0.00231	CcSEcCtD
Clodronate—Pharyngitis—Raloxifene—osteoporosis	0.000126	0.00224	CcSEcCtD
Clodronate—Decreased appetite—Ergocalciferol—osteoporosis	0.000126	0.00224	CcSEcCtD
Clodronate—Urinary tract disorder—Raloxifene—osteoporosis	0.000125	0.00223	CcSEcCtD
Clodronate—Connective tissue disorder—Raloxifene—osteoporosis	0.000125	0.00222	CcSEcCtD
Clodronate—Pharyngitis—Ibandronate—osteoporosis	0.000125	0.00222	CcSEcCtD
Clodronate—Urethral disorder—Raloxifene—osteoporosis	0.000125	0.00221	CcSEcCtD
Clodronate—Urinary tract disorder—Ibandronate—osteoporosis	0.000124	0.00221	CcSEcCtD
Clodronate—Connective tissue disorder—Ibandronate—osteoporosis	0.000124	0.00219	CcSEcCtD
Clodronate—Urethral disorder—Ibandronate—osteoporosis	0.000123	0.00219	CcSEcCtD
Clodronate—Anaemia—Etidronic acid—osteoporosis	0.000122	0.00217	CcSEcCtD
Clodronate—Blood creatinine increased—Zoledronate—osteoporosis	0.000122	0.00216	CcSEcCtD
Clodronate—Bronchospasm—Pamidronate—osteoporosis	0.000121	0.00215	CcSEcCtD
Clodronate—Dehydration—Zoledronate—osteoporosis	0.000121	0.00215	CcSEcCtD
Clodronate—Angioedema—Etidronic acid—osteoporosis	0.000121	0.00214	CcSEcCtD
Clodronate—Abdominal pain upper—Zoledronate—osteoporosis	0.000119	0.00211	CcSEcCtD
Clodronate—Mediastinal disorder—Estropipate—osteoporosis	0.000118	0.0021	CcSEcCtD
Clodronate—Blood creatinine increased—Conjugated Estrogens—osteoporosis	0.000117	0.00208	CcSEcCtD
Clodronate—Dehydration—Conjugated Estrogens—osteoporosis	0.000116	0.00207	CcSEcCtD
Clodronate—Pneumonia—Risedronate—osteoporosis	0.000116	0.00206	CcSEcCtD
Clodronate—Pruritus—Calcium Acetate—osteoporosis	0.000116	0.00206	CcSEcCtD
Clodronate—Hepatic function abnormal—Estradiol—osteoporosis	0.000115	0.00204	CcSEcCtD
Clodronate—Mediastinal disorder—Ibandronate—osteoporosis	0.000113	0.00201	CcSEcCtD
Clodronate—Dysphagia—Zoledronate—osteoporosis	0.000112	0.002	CcSEcCtD
Clodronate—Diarrhoea—Calcium Acetate—osteoporosis	0.000112	0.00199	CcSEcCtD
Clodronate—Bronchospasm—Zoledronate—osteoporosis	0.000111	0.00196	CcSEcCtD
Clodronate—Pneumonia—Pamidronate—osteoporosis	0.00011	0.00196	CcSEcCtD
Clodronate—Dysphagia—Conjugated Estrogens—osteoporosis	0.000108	0.00192	CcSEcCtD
Clodronate—Renal failure—Pamidronate—osteoporosis	0.000108	0.00192	CcSEcCtD
Clodronate—Infection—Etidronic acid—osteoporosis	0.000107	0.0019	CcSEcCtD
Clodronate—Bronchospasm—Conjugated Estrogens—osteoporosis	0.000106	0.00189	CcSEcCtD
Clodronate—Pharyngitis—Ethinyl Estradiol—osteoporosis	0.000105	0.00187	CcSEcCtD
Clodronate—Urinary tract disorder—Ethinyl Estradiol—osteoporosis	0.000105	0.00186	CcSEcCtD
Clodronate—Connective tissue disorder—Ethinyl Estradiol—osteoporosis	0.000104	0.00186	CcSEcCtD
Clodronate—Angioedema—Estropipate—osteoporosis	0.000104	0.00185	CcSEcCtD
Clodronate—Vomiting—Calcium Acetate—osteoporosis	0.000104	0.00185	CcSEcCtD
Clodronate—Urethral disorder—Ethinyl Estradiol—osteoporosis	0.000104	0.00185	CcSEcCtD
Clodronate—Anaemia—Alendronate—osteoporosis	0.000104	0.00185	CcSEcCtD
Clodronate—Pharyngitis—Risedronate—osteoporosis	0.000103	0.00183	CcSEcCtD
Clodronate—Angioedema—Alendronate—osteoporosis	0.000103	0.00182	CcSEcCtD
Clodronate—Urinary tract disorder—Risedronate—osteoporosis	0.000102	0.00182	CcSEcCtD
Clodronate—Connective tissue disorder—Risedronate—osteoporosis	0.000102	0.00181	CcSEcCtD
Clodronate—Urethral disorder—Risedronate—osteoporosis	0.000102	0.0018	CcSEcCtD
Clodronate—Anaemia—Ibandronate—osteoporosis	0.000101	0.0018	CcSEcCtD
Clodronate—SLC25A4—Disease—PKM—osteoporosis	0.000101	0.00363	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SOST—osteoporosis	0.000101	0.00363	CbGpPWpGaD
Clodronate—Angioedema—Ibandronate—osteoporosis	0.0001	0.00178	CcSEcCtD
Clodronate—SLC25A5—Disease—RPL24—osteoporosis	9.91e-05	0.00358	CbGpPWpGaD
Clodronate—SLC25A5—Disease—LTF—osteoporosis	9.91e-05	0.00358	CbGpPWpGaD
Clodronate—Renal failure—Zoledronate—osteoporosis	9.85e-05	0.00175	CcSEcCtD
Clodronate—Nausea—Calcium Acetate—osteoporosis	9.74e-05	0.00173	CcSEcCtD
Clodronate—Urinary tract disorder—Pamidronate—osteoporosis	9.73e-05	0.00173	CcSEcCtD
Clodronate—Connective tissue disorder—Pamidronate—osteoporosis	9.68e-05	0.00172	CcSEcCtD
Clodronate—Urethral disorder—Pamidronate—osteoporosis	9.66e-05	0.00172	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	9.65e-05	0.00171	CcSEcCtD
Clodronate—SLC25A4—Disease—PGLS—osteoporosis	9.54e-05	0.00344	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ANTXR2—osteoporosis	9.54e-05	0.00344	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—OXCT1—osteoporosis	9.5e-05	0.00343	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CA2—osteoporosis	9.5e-05	0.00343	CbGpPWpGaD
Clodronate—Renal failure—Conjugated Estrogens—osteoporosis	9.49e-05	0.00169	CcSEcCtD
Clodronate—Dyspepsia—Etidronic acid—osteoporosis	9.48e-05	0.00168	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL6R—osteoporosis	9.43e-05	0.0034	CbGpPWpGaD
Clodronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	9.39e-05	0.00339	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PNP—osteoporosis	9.36e-05	0.00338	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ATIC—osteoporosis	9.36e-05	0.00338	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	9.35e-05	0.00166	CcSEcCtD
Clodronate—Mediastinal disorder—Risedronate—osteoporosis	9.34e-05	0.00166	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—TLN1—osteoporosis	9.26e-05	0.00334	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—MGLL—osteoporosis	9.26e-05	0.00334	CbGpPWpGaD
Clodronate—Infection—Estropipate—osteoporosis	9.26e-05	0.00164	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	9.25e-05	0.00164	CcSEcCtD
Clodronate—Abdominal pain upper—Estradiol—osteoporosis	9.15e-05	0.00163	CcSEcCtD
Clodronate—Infection—Alendronate—osteoporosis	9.12e-05	0.00162	CcSEcCtD
Clodronate—Skin disorder—Estropipate—osteoporosis	9.05e-05	0.00161	CcSEcCtD
Clodronate—SLC25A6—Disease—LRP5—osteoporosis	9.04e-05	0.00326	CbGpPWpGaD
Clodronate—Infection—Raloxifene—osteoporosis	8.96e-05	0.00159	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—REN—osteoporosis	8.9e-05	0.00321	CbGpPWpGaD
Clodronate—Urinary tract disorder—Zoledronate—osteoporosis	8.89e-05	0.00158	CcSEcCtD
Clodronate—Mediastinal disorder—Pamidronate—osteoporosis	8.88e-05	0.00158	CcSEcCtD
Clodronate—Infection—Ibandronate—osteoporosis	8.88e-05	0.00158	CcSEcCtD
Clodronate—Connective tissue disorder—Zoledronate—osteoporosis	8.84e-05	0.00157	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Estradiol—osteoporosis	8.84e-05	0.00157	CcSEcCtD
Clodronate—Urethral disorder—Zoledronate—osteoporosis	8.82e-05	0.00157	CcSEcCtD
Clodronate—Skin disorder—Raloxifene—osteoporosis	8.77e-05	0.00156	CcSEcCtD
Clodronate—Skin disorder—Ibandronate—osteoporosis	8.68e-05	0.00154	CcSEcCtD
Clodronate—Dysphagia—Estradiol—osteoporosis	8.66e-05	0.00154	CcSEcCtD
Clodronate—SLC25A6—Disease—LRP6—osteoporosis	8.65e-05	0.00312	CbGpPWpGaD
Clodronate—Nausea—Ergocalciferol—osteoporosis	8.61e-05	0.00153	CcSEcCtD
Clodronate—Pharyngitis—Conjugated Estrogens—osteoporosis	8.6e-05	0.00153	CcSEcCtD
Clodronate—SLC25A5—Disease—ACP5—osteoporosis	8.6e-05	0.0031	CbGpPWpGaD
Clodronate—Urticaria—Etidronic acid—osteoporosis	8.55e-05	0.00152	CcSEcCtD
Clodronate—Bronchospasm—Estradiol—osteoporosis	8.52e-05	0.00151	CcSEcCtD
Clodronate—Abdominal pain—Etidronic acid—osteoporosis	8.51e-05	0.00151	CcSEcCtD
Clodronate—Skin disorder—Calcitriol—osteoporosis	8.49e-05	0.00151	CcSEcCtD
Clodronate—Angioedema—Ethinyl Estradiol—osteoporosis	8.45e-05	0.0015	CcSEcCtD
Clodronate—SLC25A4—Metabolism—FDPS—osteoporosis	8.43e-05	0.00304	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PKM—osteoporosis	8.43e-05	0.00304	CbGpPWpGaD
Clodronate—Anaemia—Risedronate—osteoporosis	8.34e-05	0.00148	CcSEcCtD
Clodronate—Anorexia—Calcitriol—osteoporosis	8.34e-05	0.00148	CcSEcCtD
Clodronate—SLC25A6—Disease—RPL24—osteoporosis	8.31e-05	0.003	CbGpPWpGaD
Clodronate—SLC25A6—Disease—LTF—osteoporosis	8.31e-05	0.003	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—COL1A2—osteoporosis	8.29e-05	0.00299	CbGpPWpGaD
Clodronate—Angioedema—Risedronate—osteoporosis	8.24e-05	0.00146	CcSEcCtD
Clodronate—Dyspepsia—Estropipate—osteoporosis	8.2e-05	0.00146	CcSEcCtD
Clodronate—SLC25A4—Disease—GSN—osteoporosis	8.11e-05	0.00293	CbGpPWpGaD
Clodronate—Mediastinal disorder—Zoledronate—osteoporosis	8.11e-05	0.00144	CcSEcCtD
Clodronate—Dyspepsia—Alendronate—osteoporosis	8.08e-05	0.00143	CcSEcCtD
Clodronate—Gastrointestinal disorder—Estropipate—osteoporosis	8.04e-05	0.00143	CcSEcCtD
Clodronate—SLC25A5—Disease—TPI1—osteoporosis	7.99e-05	0.00289	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GPD2—osteoporosis	7.99e-05	0.00288	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PGLS—osteoporosis	7.99e-05	0.00288	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—OXCT1—osteoporosis	7.96e-05	0.00287	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CA2—osteoporosis	7.96e-05	0.00287	CbGpPWpGaD
Clodronate—Dyspepsia—Raloxifene—osteoporosis	7.94e-05	0.00141	CcSEcCtD
Clodronate—Anaemia—Pamidronate—osteoporosis	7.93e-05	0.00141	CcSEcCtD
Clodronate—SLC25A5—Metabolism—IDH2—osteoporosis	7.87e-05	0.00284	CbGpPWpGaD
Clodronate—Dyspepsia—Ibandronate—osteoporosis	7.86e-05	0.0014	CcSEcCtD
Clodronate—Angioedema—Pamidronate—osteoporosis	7.84e-05	0.00139	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	7.82e-05	0.00139	CcSEcCtD
Clodronate—Mediastinal disorder—Conjugated Estrogens—osteoporosis	7.81e-05	0.00139	CcSEcCtD
Clodronate—Gastrointestinal disorder—Raloxifene—osteoporosis	7.79e-05	0.00138	CcSEcCtD
Clodronate—Pneumonia—Estradiol—osteoporosis	7.77e-05	0.00138	CcSEcCtD
Clodronate—Decreased appetite—Ibandronate—osteoporosis	7.77e-05	0.00138	CcSEcCtD
Clodronate—SLC25A6—Metabolism—MGLL—osteoporosis	7.76e-05	0.0028	CbGpPWpGaD
Clodronate—SLC25A6—Influenza Infection—TGFB1—osteoporosis	7.74e-05	0.00279	CbGpPWpGaD
Clodronate—Gastrointestinal disorder—Ibandronate—osteoporosis	7.71e-05	0.00137	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	7.63e-05	0.00135	CcSEcCtD
Clodronate—Pruritus—Etidronic acid—osteoporosis	7.62e-05	0.00135	CcSEcCtD
Clodronate—Decreased appetite—Calcitriol—osteoporosis	7.6e-05	0.00135	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—WNT1—osteoporosis	7.53e-05	0.00272	CbGpPWpGaD
Clodronate—SLC25A5—Disease—P4HB—osteoporosis	7.51e-05	0.00271	CbGpPWpGaD
Clodronate—Infection—Ethinyl Estradiol—osteoporosis	7.5e-05	0.00133	CcSEcCtD
Clodronate—Urticaria—Estropipate—osteoporosis	7.4e-05	0.00131	CcSEcCtD
Clodronate—SLC25A5—Metabolism—CYP27A1—osteoporosis	7.4e-05	0.00267	CbGpPWpGaD
Clodronate—SLC25A5—Disease—GAPDH—osteoporosis	7.38e-05	0.00266	CbGpPWpGaD
Clodronate—Diarrhoea—Etidronic acid—osteoporosis	7.37e-05	0.00131	CcSEcCtD
Clodronate—Abdominal pain—Estropipate—osteoporosis	7.36e-05	0.00131	CcSEcCtD
Clodronate—Skin disorder—Ethinyl Estradiol—osteoporosis	7.33e-05	0.0013	CcSEcCtD
Clodronate—Infection—Risedronate—osteoporosis	7.31e-05	0.0013	CcSEcCtD
Clodronate—SLC25A4—Metabolism—ATIC—osteoporosis	7.31e-05	0.00264	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PNP—osteoporosis	7.31e-05	0.00264	CbGpPWpGaD
Clodronate—Urticaria—Alendronate—osteoporosis	7.29e-05	0.00129	CcSEcCtD
Clodronate—Abdominal pain—Alendronate—osteoporosis	7.25e-05	0.00129	CcSEcCtD
Clodronate—Anaemia—Zoledronate—osteoporosis	7.24e-05	0.00129	CcSEcCtD
Clodronate—SLC25A6—Disease—ACP5—osteoporosis	7.2e-05	0.0026	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ACP5—osteoporosis	7.2e-05	0.0026	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL1B—osteoporosis	7.17e-05	0.00259	CbGpPWpGaD
Clodronate—Angioedema—Zoledronate—osteoporosis	7.16e-05	0.00127	CcSEcCtD
Clodronate—Skin disorder—Risedronate—osteoporosis	7.15e-05	0.00127	CcSEcCtD
Clodronate—Abdominal pain—Raloxifene—osteoporosis	7.13e-05	0.00127	CcSEcCtD
Clodronate—SLC25A6—Metabolism of proteins—ACE—osteoporosis	7.12e-05	0.00257	CbGpPWpGaD
Clodronate—Urticaria—Ibandronate—osteoporosis	7.1e-05	0.00126	CcSEcCtD
Clodronate—Abdominal pain—Ibandronate—osteoporosis	7.06e-05	0.00125	CcSEcCtD
Clodronate—SLC25A4—Disease—LRP5—osteoporosis	7.06e-05	0.00255	CbGpPWpGaD
Clodronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoporosis	7.02e-05	0.00253	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NFATC1—osteoporosis	7.01e-05	0.00253	CbGpPWpGaD
Clodronate—Infection—Pamidronate—osteoporosis	6.95e-05	0.00124	CcSEcCtD
Clodronate—SLC25A5—Disease—DKK1—osteoporosis	6.95e-05	0.00251	CbGpPWpGaD
Clodronate—Urticaria—Calcitriol—osteoporosis	6.95e-05	0.00123	CcSEcCtD
Clodronate—Abdominal pain—Calcitriol—osteoporosis	6.91e-05	0.00123	CcSEcCtD
Clodronate—Angioedema—Conjugated Estrogens—osteoporosis	6.89e-05	0.00122	CcSEcCtD
Clodronate—Pharyngitis—Estradiol—osteoporosis	6.88e-05	0.00122	CcSEcCtD
Clodronate—Urinary tract disorder—Estradiol—osteoporosis	6.85e-05	0.00122	CcSEcCtD
Clodronate—Vomiting—Etidronic acid—osteoporosis	6.85e-05	0.00122	CcSEcCtD
Clodronate—Connective tissue disorder—Estradiol—osteoporosis	6.81e-05	0.00121	CcSEcCtD
Clodronate—Urethral disorder—Estradiol—osteoporosis	6.8e-05	0.00121	CcSEcCtD
Clodronate—Rash—Etidronic acid—osteoporosis	6.79e-05	0.00121	CcSEcCtD
Clodronate—Dermatitis—Etidronic acid—osteoporosis	6.78e-05	0.0012	CcSEcCtD
Clodronate—SLC25A4—Disease—LRP6—osteoporosis	6.75e-05	0.00244	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TPI1—osteoporosis	6.7e-05	0.00242	CbGpPWpGaD
Clodronate—SLC25A5—Disease—WNT1—osteoporosis	6.7e-05	0.00242	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—TPI1—osteoporosis	6.69e-05	0.00242	CbGpPWpGaD
Clodronate—Anorexia—Pamidronate—osteoporosis	6.67e-05	0.00119	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	6.62e-05	0.00118	CcSEcCtD
Clodronate—SLC25A6—Metabolism—IDH2—osteoporosis	6.6e-05	0.00238	CbGpPWpGaD
Clodronate—Pruritus—Estropipate—osteoporosis	6.59e-05	0.00117	CcSEcCtD
Clodronate—Dyspnoea—Risedronate—osteoporosis	6.56e-05	0.00117	CcSEcCtD
Clodronate—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	6.52e-05	0.00116	CcSEcCtD
Clodronate—SLC25A5—Disease—FGA—osteoporosis	6.51e-05	0.00235	CbGpPWpGaD
Clodronate—Pruritus—Alendronate—osteoporosis	6.49e-05	0.00115	CcSEcCtD
Clodronate—SLC25A4—Disease—LTF—osteoporosis	6.49e-05	0.00234	CbGpPWpGaD
Clodronate—SLC25A4—Disease—RPL24—osteoporosis	6.49e-05	0.00234	CbGpPWpGaD
Clodronate—Dyspepsia—Risedronate—osteoporosis	6.48e-05	0.00115	CcSEcCtD
Clodronate—PTGS2—Arachidonic acid metabolism—GPX1—osteoporosis	6.43e-05	0.00232	CbGpPWpGaD
Clodronate—Nausea—Etidronic acid—osteoporosis	6.4e-05	0.00114	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	6.38e-05	0.00113	CcSEcCtD
Clodronate—Diarrhoea—Estropipate—osteoporosis	6.37e-05	0.00113	CcSEcCtD
Clodronate—Gastrointestinal disorder—Risedronate—osteoporosis	6.36e-05	0.00113	CcSEcCtD
Clodronate—Infection—Zoledronate—osteoporosis	6.35e-05	0.00113	CcSEcCtD
Clodronate—Pruritus—Ibandronate—osteoporosis	6.32e-05	0.00112	CcSEcCtD
Clodronate—SLC25A6—Disease—P4HB—osteoporosis	6.3e-05	0.00227	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—P4HB—osteoporosis	6.29e-05	0.00227	CbGpPWpGaD
Clodronate—Diarrhoea—Alendronate—osteoporosis	6.28e-05	0.00112	CcSEcCtD
Clodronate—Mediastinal disorder—Estradiol—osteoporosis	6.25e-05	0.00111	CcSEcCtD
Clodronate—Dyspnoea—Pamidronate—osteoporosis	6.24e-05	0.00111	CcSEcCtD
Clodronate—SLC25A4—Metabolism—CA2—osteoporosis	6.21e-05	0.00224	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—OXCT1—osteoporosis	6.21e-05	0.00224	CbGpPWpGaD
Clodronate—Skin disorder—Zoledronate—osteoporosis	6.21e-05	0.0011	CcSEcCtD
Clodronate—SLC25A6—Metabolism—CYP27A1—osteoporosis	6.2e-05	0.00224	CbGpPWpGaD
Clodronate—Pruritus—Calcitriol—osteoporosis	6.19e-05	0.0011	CcSEcCtD
Clodronate—PTGS2—uterus—osteoporosis	6.19e-05	0.033	CbGeAlD
Clodronate—SLC25A6—Disease—GAPDH—osteoporosis	6.18e-05	0.00223	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GAPDH—osteoporosis	6.18e-05	0.00223	CbGpPWpGaD
Clodronate—Diarrhoea—Raloxifene—osteoporosis	6.17e-05	0.0011	CcSEcCtD
Clodronate—Dyspepsia—Pamidronate—osteoporosis	6.16e-05	0.00109	CcSEcCtD
Clodronate—Infection—Conjugated Estrogens—osteoporosis	6.12e-05	0.00109	CcSEcCtD
Clodronate—Diarrhoea—Ibandronate—osteoporosis	6.11e-05	0.00109	CcSEcCtD
Clodronate—Anorexia—Zoledronate—osteoporosis	6.09e-05	0.00108	CcSEcCtD
Clodronate—Decreased appetite—Pamidronate—osteoporosis	6.08e-05	0.00108	CcSEcCtD
Clodronate—SLC25A4—Metabolism—MGLL—osteoporosis	6.06e-05	0.00219	CbGpPWpGaD
Clodronate—Gastrointestinal disorder—Pamidronate—osteoporosis	6.04e-05	0.00107	CcSEcCtD
Clodronate—SLC25A6—Metabolism—ACP5—osteoporosis	6.03e-05	0.00218	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—RAP1A—osteoporosis	6.02e-05	0.00217	CbGpPWpGaD
Clodronate—Urticaria—Ethinyl Estradiol—osteoporosis	6e-05	0.00107	CcSEcCtD
Clodronate—Diarrhoea—Calcitriol—osteoporosis	5.98e-05	0.00106	CcSEcCtD
Clodronate—Skin disorder—Conjugated Estrogens—osteoporosis	5.98e-05	0.00106	CcSEcCtD
Clodronate—Abdominal pain—Ethinyl Estradiol—osteoporosis	5.97e-05	0.00106	CcSEcCtD
Clodronate—Vomiting—Estropipate—osteoporosis	5.92e-05	0.00105	CcSEcCtD
Clodronate—Rash—Estropipate—osteoporosis	5.87e-05	0.00104	CcSEcCtD
Clodronate—SLC25A6—Disease—NFATC1—osteoporosis	5.87e-05	0.00212	CbGpPWpGaD
Clodronate—Dermatitis—Estropipate—osteoporosis	5.87e-05	0.00104	CcSEcCtD
Clodronate—Anorexia—Conjugated Estrogens—osteoporosis	5.87e-05	0.00104	CcSEcCtD
Clodronate—Urticaria—Risedronate—osteoporosis	5.85e-05	0.00104	CcSEcCtD
Clodronate—Vomiting—Alendronate—osteoporosis	5.83e-05	0.00104	CcSEcCtD
Clodronate—SLC25A6—Disease—DKK1—osteoporosis	5.83e-05	0.0021	CbGpPWpGaD
Clodronate—Abdominal pain—Risedronate—osteoporosis	5.82e-05	0.00103	CcSEcCtD
Clodronate—SLC25A5—Disease—ENO1—osteoporosis	5.81e-05	0.0021	CbGpPWpGaD
Clodronate—Rash—Alendronate—osteoporosis	5.79e-05	0.00103	CcSEcCtD
Clodronate—Dermatitis—Alendronate—osteoporosis	5.78e-05	0.00103	CcSEcCtD
Clodronate—Vomiting—Raloxifene—osteoporosis	5.74e-05	0.00102	CcSEcCtD
Clodronate—SLC25A5—Disease—PSMA2—osteoporosis	5.72e-05	0.00207	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PSMA5—osteoporosis	5.72e-05	0.00207	CbGpPWpGaD
Clodronate—Dyspnoea—Zoledronate—osteoporosis	5.7e-05	0.00101	CcSEcCtD
Clodronate—Rash—Raloxifene—osteoporosis	5.69e-05	0.00101	CcSEcCtD
Clodronate—Dermatitis—Raloxifene—osteoporosis	5.68e-05	0.00101	CcSEcCtD
Clodronate—Vomiting—Ibandronate—osteoporosis	5.68e-05	0.00101	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	5.64e-05	0.00204	CbGpPWpGaD
Clodronate—Rash—Ibandronate—osteoporosis	5.63e-05	0.001	CcSEcCtD
Clodronate—Dermatitis—Ibandronate—osteoporosis	5.63e-05	0.001	CcSEcCtD
Clodronate—Dyspepsia—Zoledronate—osteoporosis	5.63e-05	0.001	CcSEcCtD
Clodronate—SLC25A4—Disease—ACP5—osteoporosis	5.62e-05	0.00203	CbGpPWpGaD
Clodronate—SLC25A6—Disease—WNT1—osteoporosis	5.61e-05	0.00203	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—TPI1—osteoporosis	5.61e-05	0.00202	CbGpPWpGaD
Clodronate—Vomiting—Calcitriol—osteoporosis	5.56e-05	0.000988	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—ACE—osteoporosis	5.56e-05	0.00201	CbGpPWpGaD
Clodronate—Decreased appetite—Zoledronate—osteoporosis	5.56e-05	0.000987	CcSEcCtD
Clodronate—PTGS2—Overview of nanoparticle effects—TNF—osteoporosis	5.54e-05	0.002	CbGpPWpGaD
Clodronate—Nausea—Estropipate—osteoporosis	5.53e-05	0.000983	CcSEcCtD
Clodronate—Abdominal pain—Pamidronate—osteoporosis	5.53e-05	0.000983	CcSEcCtD
Clodronate—Gastrointestinal disorder—Zoledronate—osteoporosis	5.52e-05	0.00098	CcSEcCtD
Clodronate—Angioedema—Estradiol—osteoporosis	5.52e-05	0.00098	CcSEcCtD
Clodronate—Rash—Calcitriol—osteoporosis	5.51e-05	0.000979	CcSEcCtD
Clodronate—Dermatitis—Calcitriol—osteoporosis	5.51e-05	0.000979	CcSEcCtD
Clodronate—Dyspnoea—Conjugated Estrogens—osteoporosis	5.49e-05	0.000975	CcSEcCtD
Clodronate—SLC25A6—Disease—FGA—osteoporosis	5.46e-05	0.00197	CbGpPWpGaD
Clodronate—Nausea—Alendronate—osteoporosis	5.45e-05	0.000968	CcSEcCtD
Clodronate—Dyspepsia—Conjugated Estrogens—osteoporosis	5.42e-05	0.000963	CcSEcCtD
Clodronate—Nausea—Raloxifene—osteoporosis	5.36e-05	0.000952	CcSEcCtD
Clodronate—Decreased appetite—Conjugated Estrogens—osteoporosis	5.35e-05	0.000951	CcSEcCtD
Clodronate—Pruritus—Ethinyl Estradiol—osteoporosis	5.34e-05	0.000949	CcSEcCtD
Clodronate—SLC25A5—Disease—CALCA—osteoporosis	5.33e-05	0.00192	CbGpPWpGaD
Clodronate—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	5.31e-05	0.000944	CcSEcCtD
Clodronate—Nausea—Ibandronate—osteoporosis	5.31e-05	0.000943	CcSEcCtD
Clodronate—SLC25A6—Metabolism—P4HB—osteoporosis	5.27e-05	0.0019	CbGpPWpGaD
Clodronate—PTGS2—bone marrow—osteoporosis	5.25e-05	0.028	CbGeAlD
Clodronate—SLC25A4—Disease—TPI1—osteoporosis	5.23e-05	0.00189	CbGpPWpGaD
Clodronate—Pruritus—Risedronate—osteoporosis	5.21e-05	0.000925	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—TNF—osteoporosis	5.2e-05	0.00188	CbGpPWpGaD
Clodronate—Nausea—Calcitriol—osteoporosis	5.19e-05	0.000923	CcSEcCtD
Clodronate—SLC25A6—Metabolism—GAPDH—osteoporosis	5.18e-05	0.00187	CbGpPWpGaD
Clodronate—Diarrhoea—Ethinyl Estradiol—osteoporosis	5.17e-05	0.000918	CcSEcCtD
Clodronate—SLC25A4—Metabolism—IDH2—osteoporosis	5.15e-05	0.00186	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	5.1e-05	0.000907	CcSEcCtD
Clodronate—Urticaria—Zoledronate—osteoporosis	5.08e-05	0.000902	CcSEcCtD
Clodronate—Abdominal pain—Zoledronate—osteoporosis	5.05e-05	0.000898	CcSEcCtD
Clodronate—SLC25A6—Metabolism—RAP1A—osteoporosis	5.04e-05	0.00182	CbGpPWpGaD
Clodronate—Diarrhoea—Risedronate—osteoporosis	5.04e-05	0.000895	CcSEcCtD
Clodronate—Pruritus—Pamidronate—osteoporosis	4.95e-05	0.00088	CcSEcCtD
Clodronate—SLC25A4—Disease—P4HB—osteoporosis	4.92e-05	0.00177	CbGpPWpGaD
Clodronate—Infection—Estradiol—osteoporosis	4.89e-05	0.000869	CcSEcCtD
Clodronate—Urticaria—Conjugated Estrogens—osteoporosis	4.89e-05	0.000869	CcSEcCtD
Clodronate—Abdominal pain—Conjugated Estrogens—osteoporosis	4.87e-05	0.000864	CcSEcCtD
Clodronate—SLC25A6—Disease—ENO1—osteoporosis	4.87e-05	0.00176	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ENO1—osteoporosis	4.86e-05	0.00176	CbGpPWpGaD
Clodronate—SLC25A5—Disease—KL—osteoporosis	4.84e-05	0.00175	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYP27A1—osteoporosis	4.84e-05	0.00175	CbGpPWpGaD
Clodronate—SLC25A4—Disease—GAPDH—osteoporosis	4.82e-05	0.00174	CbGpPWpGaD
Clodronate—Vomiting—Ethinyl Estradiol—osteoporosis	4.8e-05	0.000853	CcSEcCtD
Clodronate—SLC25A6—Disease—PSMA5—osteoporosis	4.79e-05	0.00173	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PSMA2—osteoporosis	4.79e-05	0.00173	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PSMA5—osteoporosis	4.79e-05	0.00173	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PSMA2—osteoporosis	4.79e-05	0.00173	CbGpPWpGaD
Clodronate—Diarrhoea—Pamidronate—osteoporosis	4.79e-05	0.000851	CcSEcCtD
Clodronate—Skin disorder—Estradiol—osteoporosis	4.79e-05	0.00085	CcSEcCtD
Clodronate—Rash—Ethinyl Estradiol—osteoporosis	4.76e-05	0.000846	CcSEcCtD
Clodronate—Dermatitis—Ethinyl Estradiol—osteoporosis	4.76e-05	0.000845	CcSEcCtD
Clodronate—SLC25A4—Metabolism—ACP5—osteoporosis	4.71e-05	0.0017	CbGpPWpGaD
Clodronate—Vomiting—Risedronate—osteoporosis	4.68e-05	0.000832	CcSEcCtD
Clodronate—Rash—Risedronate—osteoporosis	4.64e-05	0.000825	CcSEcCtD
Clodronate—Dermatitis—Risedronate—osteoporosis	4.64e-05	0.000824	CcSEcCtD
Clodronate—SLC25A4—Disease—NFATC1—osteoporosis	4.58e-05	0.00166	CbGpPWpGaD
Clodronate—SLC25A4—Disease—DKK1—osteoporosis	4.55e-05	0.00164	CbGpPWpGaD
Clodronate—Pruritus—Zoledronate—osteoporosis	4.52e-05	0.000803	CcSEcCtD
Clodronate—Nausea—Ethinyl Estradiol—osteoporosis	4.49e-05	0.000797	CcSEcCtD
Clodronate—PTGS2—Overview of nanoparticle effects—IL6—osteoporosis	4.47e-05	0.00162	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CALCA—osteoporosis	4.47e-05	0.00161	CbGpPWpGaD
Clodronate—Vomiting—Pamidronate—osteoporosis	4.45e-05	0.00079	CcSEcCtD
Clodronate—SLC25A6—Metabolism of proteins—LEP—osteoporosis	4.42e-05	0.0016	CbGpPWpGaD
Clodronate—Rash—Pamidronate—osteoporosis	4.41e-05	0.000784	CcSEcCtD
Clodronate—Dermatitis—Pamidronate—osteoporosis	4.41e-05	0.000783	CcSEcCtD
Clodronate—Dyspnoea—Estradiol—osteoporosis	4.39e-05	0.00078	CcSEcCtD
Clodronate—SLC25A4—Disease—WNT1—osteoporosis	4.38e-05	0.00158	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—TPI1—osteoporosis	4.38e-05	0.00158	CbGpPWpGaD
Clodronate—Diarrhoea—Zoledronate—osteoporosis	4.37e-05	0.000777	CcSEcCtD
Clodronate—Nausea—Risedronate—osteoporosis	4.37e-05	0.000777	CcSEcCtD
Clodronate—Pruritus—Conjugated Estrogens—osteoporosis	4.36e-05	0.000774	CcSEcCtD
Clodronate—Dyspepsia—Estradiol—osteoporosis	4.34e-05	0.00077	CcSEcCtD
Clodronate—PTGS2—Selenium Micronutrient Network—SOD2—osteoporosis	4.29e-05	0.00155	CbGpPWpGaD
Clodronate—Decreased appetite—Estradiol—osteoporosis	4.28e-05	0.000761	CcSEcCtD
Clodronate—SLC25A4—Disease—FGA—osteoporosis	4.26e-05	0.00154	CbGpPWpGaD
Clodronate—Gastrointestinal disorder—Estradiol—osteoporosis	4.25e-05	0.000756	CcSEcCtD
Clodronate—Diarrhoea—Conjugated Estrogens—osteoporosis	4.21e-05	0.000748	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL6—osteoporosis	4.2e-05	0.00152	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	4.18e-05	0.00151	CbGpPWpGaD
Clodronate—Nausea—Pamidronate—osteoporosis	4.16e-05	0.000738	CcSEcCtD
Clodronate—SLC25A4—Metabolism—P4HB—osteoporosis	4.12e-05	0.00149	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—GPX1—osteoporosis	4.09e-05	0.00148	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ENO1—osteoporosis	4.08e-05	0.00147	CbGpPWpGaD
Clodronate—Vomiting—Zoledronate—osteoporosis	4.06e-05	0.000722	CcSEcCtD
Clodronate—SLC25A6—Disease—KL—osteoporosis	4.06e-05	0.00146	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GAPDH—osteoporosis	4.04e-05	0.00146	CbGpPWpGaD
Clodronate—Rash—Zoledronate—osteoporosis	4.03e-05	0.000716	CcSEcCtD
Clodronate—Dermatitis—Zoledronate—osteoporosis	4.03e-05	0.000715	CcSEcCtD
Clodronate—SLC25A6—Metabolism—PSMA2—osteoporosis	4.02e-05	0.00145	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PSMA5—osteoporosis	4.02e-05	0.00145	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—RAP1A—osteoporosis	3.94e-05	0.00142	CbGpPWpGaD
Clodronate—Vomiting—Conjugated Estrogens—osteoporosis	3.91e-05	0.000695	CcSEcCtD
Clodronate—Urticaria—Estradiol—osteoporosis	3.91e-05	0.000695	CcSEcCtD
Clodronate—Abdominal pain—Estradiol—osteoporosis	3.89e-05	0.000692	CcSEcCtD
Clodronate—SLC25A5—Metabolism—CYP19A1—osteoporosis	3.89e-05	0.0014	CbGpPWpGaD
Clodronate—Rash—Conjugated Estrogens—osteoporosis	3.88e-05	0.000689	CcSEcCtD
Clodronate—Dermatitis—Conjugated Estrogens—osteoporosis	3.88e-05	0.000689	CcSEcCtD
Clodronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	3.81e-05	0.00138	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—POMC—osteoporosis	3.8e-05	0.00137	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ENO1—osteoporosis	3.8e-05	0.00137	CbGpPWpGaD
Clodronate—Nausea—Zoledronate—osteoporosis	3.8e-05	0.000675	CcSEcCtD
Clodronate—SLC25A5—Disease—ADCY5—osteoporosis	3.79e-05	0.00137	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—MTHFR—osteoporosis	3.78e-05	0.00136	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PSMA5—osteoporosis	3.74e-05	0.00135	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PSMA2—osteoporosis	3.74e-05	0.00135	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.74e-05	0.00135	CbGpPWpGaD
Clodronate—Nausea—Conjugated Estrogens—osteoporosis	3.66e-05	0.000649	CcSEcCtD
Clodronate—SLC25A6—Metabolism of proteins—IGF1—osteoporosis	3.65e-05	0.00132	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.55e-05	0.00128	CbGpPWpGaD
Clodronate—SLC25A5—Disease—MTHFR—osteoporosis	3.49e-05	0.00126	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CALCA—osteoporosis	3.49e-05	0.00126	CbGpPWpGaD
Clodronate—Pruritus—Estradiol—osteoporosis	3.49e-05	0.000619	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—LEP—osteoporosis	3.45e-05	0.00125	CbGpPWpGaD
Clodronate—Diarrhoea—Estradiol—osteoporosis	3.37e-05	0.000599	CcSEcCtD
Clodronate—SLC25A5—Disease—IRS2—osteoporosis	3.32e-05	0.0012	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CYP19A1—osteoporosis	3.26e-05	0.00118	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ENO1—osteoporosis	3.18e-05	0.00115	CbGpPWpGaD
Clodronate—SLC25A6—Disease—ADCY5—osteoporosis	3.18e-05	0.00115	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ADCY5—osteoporosis	3.18e-05	0.00115	CbGpPWpGaD
Clodronate—SLC25A4—Disease—KL—osteoporosis	3.17e-05	0.00114	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GPX1—osteoporosis	3.17e-05	0.00114	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PSMA2—osteoporosis	3.13e-05	0.00113	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PSMA5—osteoporosis	3.13e-05	0.00113	CbGpPWpGaD
Clodronate—Vomiting—Estradiol—osteoporosis	3.13e-05	0.000556	CcSEcCtD
Clodronate—Rash—Estradiol—osteoporosis	3.11e-05	0.000552	CcSEcCtD
Clodronate—Dermatitis—Estradiol—osteoporosis	3.1e-05	0.000551	CcSEcCtD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	2.98e-05	0.00107	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—POMC—osteoporosis	2.97e-05	0.00107	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	2.93e-05	0.00106	CbGpPWpGaD
Clodronate—Nausea—Estradiol—osteoporosis	2.93e-05	0.00052	CcSEcCtD
Clodronate—SLC25A6—Disease—MTHFR—osteoporosis	2.92e-05	0.00106	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—MTHFR—osteoporosis	2.92e-05	0.00105	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IRS1—osteoporosis	2.9e-05	0.00105	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—IGF1—osteoporosis	2.85e-05	0.00103	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IRS2—osteoporosis	2.78e-05	0.001	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—LEP—osteoporosis	2.78e-05	0.001	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.76e-05	0.000996	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	2.73e-05	0.000987	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6R—osteoporosis	2.72e-05	0.000982	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.69e-05	0.000971	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ADCY5—osteoporosis	2.66e-05	0.000961	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GPX1—osteoporosis	2.65e-05	0.000958	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	2.56e-05	0.000923	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYP19A1—osteoporosis	2.54e-05	0.000918	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ADCY5—osteoporosis	2.48e-05	0.000896	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—MTHFR—osteoporosis	2.45e-05	0.000884	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IRS1—osteoporosis	2.43e-05	0.000876	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—POMC—osteoporosis	2.34e-05	0.000843	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MTHFR—osteoporosis	2.28e-05	0.000824	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6R—osteoporosis	2.28e-05	0.000823	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	2.24e-05	0.000809	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IRS2—osteoporosis	2.17e-05	0.000784	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.15e-05	0.000776	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ADCY5—osteoporosis	2.08e-05	0.00075	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GPX1—osteoporosis	2.07e-05	0.000748	CbGpPWpGaD
Clodronate—PTGS2—Disease—SOST—osteoporosis	1.99e-05	0.000718	CbGpPWpGaD
Clodronate—PTGS2—Disease—PKM—osteoporosis	1.99e-05	0.000718	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—POMC—osteoporosis	1.96e-05	0.000707	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—MTHFR—osteoporosis	1.91e-05	0.00069	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IRS1—osteoporosis	1.9e-05	0.000684	CbGpPWpGaD
Clodronate—PTGS2—Disease—ANTXR2—osteoporosis	1.89e-05	0.000681	CbGpPWpGaD
Clodronate—PTGS2—Disease—PGLS—osteoporosis	1.89e-05	0.000681	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.83e-05	0.00066	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	1.81e-05	0.000654	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.81e-05	0.000652	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6R—osteoporosis	1.78e-05	0.000643	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	1.77e-05	0.00064	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PKM—osteoporosis	1.67e-05	0.000602	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—FDPS—osteoporosis	1.67e-05	0.000602	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	1.63e-05	0.000587	CbGpPWpGaD
Clodronate—SLC25A5—Disease—MYC—osteoporosis	1.61e-05	0.000582	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TGFB1—osteoporosis	1.61e-05	0.000581	CbGpPWpGaD
Clodronate—PTGS2—Disease—GSN—osteoporosis	1.6e-05	0.000579	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PGLS—osteoporosis	1.58e-05	0.00057	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GPD2—osteoporosis	1.58e-05	0.00057	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.56e-05	0.000564	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—POMC—osteoporosis	1.53e-05	0.000552	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ATIC—osteoporosis	1.44e-05	0.000522	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PNP—osteoporosis	1.44e-05	0.000522	CbGpPWpGaD
Clodronate—PTGS2—Disease—LRP5—osteoporosis	1.4e-05	0.000504	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MYC—osteoporosis	1.38e-05	0.000498	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	1.38e-05	0.000497	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MYC—osteoporosis	1.35e-05	0.000488	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TGFB1—osteoporosis	1.35e-05	0.000487	CbGpPWpGaD
Clodronate—PTGS2—Disease—LRP6—osteoporosis	1.33e-05	0.000482	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	1.31e-05	0.000474	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—osteoporosis	1.29e-05	0.000464	CbGpPWpGaD
Clodronate—PTGS2—Disease—LTF—osteoporosis	1.28e-05	0.000463	CbGpPWpGaD
Clodronate—PTGS2—Disease—RPL24—osteoporosis	1.28e-05	0.000463	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CA2—osteoporosis	1.23e-05	0.000444	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—OXCT1—osteoporosis	1.23e-05	0.000444	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6—osteoporosis	1.21e-05	0.000438	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MGLL—osteoporosis	1.2e-05	0.000432	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.13e-05	0.000408	CbGpPWpGaD
Clodronate—PTGS2—Disease—ACP5—osteoporosis	1.11e-05	0.000401	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MYC—osteoporosis	1.06e-05	0.000381	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TGFB1—osteoporosis	1.05e-05	0.00038	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL6—osteoporosis	1.04e-05	0.000375	CbGpPWpGaD
Clodronate—PTGS2—Disease—TPI1—osteoporosis	1.03e-05	0.000373	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—IDH2—osteoporosis	1.02e-05	0.000368	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6—osteoporosis	1.02e-05	0.000367	CbGpPWpGaD
Clodronate—PTGS2—Disease—P4HB—osteoporosis	9.72e-06	0.000351	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP27A1—osteoporosis	9.57e-06	0.000346	CbGpPWpGaD
Clodronate—PTGS2—Disease—GAPDH—osteoporosis	9.54e-06	0.000344	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	9.39e-06	0.000339	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	9.37e-06	0.000338	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ACP5—osteoporosis	9.31e-06	0.000336	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.19e-06	0.000332	CbGpPWpGaD
Clodronate—PTGS2—Disease—NFATC1—osteoporosis	9.06e-06	0.000327	CbGpPWpGaD
Clodronate—PTGS2—Disease—DKK1—osteoporosis	8.99e-06	0.000325	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	8.75e-06	0.000316	CbGpPWpGaD
Clodronate—PTGS2—Disease—WNT1—osteoporosis	8.66e-06	0.000313	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TPI1—osteoporosis	8.66e-06	0.000313	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGA—osteoporosis	8.43e-06	0.000304	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—P4HB—osteoporosis	8.14e-06	0.000294	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GAPDH—osteoporosis	7.99e-06	0.000288	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6—osteoporosis	7.93e-06	0.000286	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—RAP1A—osteoporosis	7.78e-06	0.000281	CbGpPWpGaD
Clodronate—PTGS2—Disease—ENO1—osteoporosis	7.51e-06	0.000271	CbGpPWpGaD
Clodronate—PTGS2—Disease—PSMA5—osteoporosis	7.4e-06	0.000267	CbGpPWpGaD
Clodronate—PTGS2—Disease—PSMA2—osteoporosis	7.4e-06	0.000267	CbGpPWpGaD
Clodronate—PTGS2—Disease—CALCA—osteoporosis	6.9e-06	0.000249	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.79e-06	0.000245	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ENO1—osteoporosis	6.29e-06	0.000227	CbGpPWpGaD
Clodronate—PTGS2—Disease—KL—osteoporosis	6.26e-06	0.000226	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PSMA2—osteoporosis	6.2e-06	0.000224	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PSMA5—osteoporosis	6.2e-06	0.000224	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP19A1—osteoporosis	5.03e-06	0.000182	CbGpPWpGaD
Clodronate—PTGS2—Disease—ADCY5—osteoporosis	4.91e-06	0.000177	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTHFR—osteoporosis	4.51e-06	0.000163	CbGpPWpGaD
Clodronate—PTGS2—Disease—IRS2—osteoporosis	4.29e-06	0.000155	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ADCY5—osteoporosis	4.11e-06	0.000148	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GPX1—osteoporosis	4.09e-06	0.000148	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MTHFR—osteoporosis	3.78e-06	0.000136	CbGpPWpGaD
Clodronate—PTGS2—Disease—IRS1—osteoporosis	3.75e-06	0.000135	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6R—osteoporosis	3.52e-06	0.000127	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—POMC—osteoporosis	3.02e-06	0.000109	CbGpPWpGaD
Clodronate—PTGS2—Disease—MYC—osteoporosis	2.09e-06	7.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFB1—osteoporosis	2.08e-06	7.51e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6—osteoporosis	1.57e-06	5.66e-05	CbGpPWpGaD
